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The Acquired Immunedeficiency Syndrome 
and related diseases 
Dr. J. S. Cheesbrough 
The first cases of the acquired immune-
deficiency syndrome (AIDS) in Malawi were 
recognised during 1985. It is inevitable that the 
number of cases will increase in the near future. 
This centre pages article is designed primarily to 
assist in case recognition. Guidelines on appro-
priate. infection control measures and conselling 
patients are also given. 
Background information 
It is now recognised that AIDS is the most 
severe manifestation of infection with the 
Human T -Iympocytotropic virus type III 
(HTLV -III). This virus replicates in 
T -lymphocytes, which are critical to the 
maintainance of the body's immune defences. In 
most people infected with this virus these 
Iympocytes appear to function normally despite 
the presence of the virus. In others however the 
virus disturbs lymphocyte function to a variable 
degree, hence HTLV -III infection can lead to a 
spectrum of diseases dependi ng on the extent and 
duration of T -Iympocyte malfunction as 




No recognised illness but 
anti-HTL V-III positive 
Fig. I Clinical Spectrum of AIDS 
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Table I 
Infections and malignancies commonly seen 
in AIDS. 
Protozoa Pfl(:umocystis carinii 
Entamoeba histolytica 
Toxoplasma gondii 
Cryptosporidi u m 











B cell lymphomas 
AIDS represents the most extreem case in 
which T -lymphocyte function is sev.erely 
deranged, so that the patient is rendered 
susceptable to a range of infections and maligna-
ncies normally held at bay by the cell mediated 
immune defences. Some of these infections and 
malignancies are very rare in the norrl1al host 
and their presence is of great assistance in case 
recognition (see table). 
When lymphocyte function is relatively less 
deranged patients may present with features of 
the AIDS-related complex (ARC) or they may 
remain well but have persistant lymphadeno-
pathy. Some patients appear to have a brief self 
limiting iIlness with fever and Iympha<;ienopathy 
clinically resembling infectious mononucelosis. 
In the majority (about 90%) the infection 'is 
subclinical, such cases are only recognised by the 
detection of antibodies to HTLV-1I1 in their 
serum. 
Patients in all these groups may be infectious, 
there seems to be no association between the 
clinical manifestations of disease and infectivity. 
This hierarchy is not stable, patients may 
downgrade from good health to AIDS years after 










































two and a half years is average). Alternatively 
they may have features of the ARC and 
subsequently improve. Recovery from full blown 
AIDS however is virtually unknown: the disease 
being invariably fatal with a median duration of 
approximately eight months from diagnosis. In 
the U.S.A. it is estimated that there is approxi-
mately one case of AIDS for every 100 cases of 
subclinical infection. 
Clinical Presentation 
I) AIDS related complex. (ARC) 
This is suggested by the finding of two or more 
of the following features: 
- Loss of 10% or more of body weight. 
- Fever of unknown origin for at least two 
months. 
- Diarrhoea for at least two months with no 
pathogen isolated. 
- Generalised lymphadenopathy consisting of 
palpable lymphnodes larger than I cm at 
any extra-inguinal site for more than three 
months. 
In the tropics a variety of diseases alone or in 
combination can lead to similar signs and 
symptoms. Treatable diseases such as T.B., 
syhilis, lymphoma, trypanosomiasis or strongy-
loidiasis must be considered and excluded. 
2) AIDS 
Many patients with AIDS have a prodromal 
illness with features of the ARC for several weeks 
or months prior to developing AIDS. Such a 
history is helpful in reaching the diagnosis. It is 
very common for AIDS patients to have been 
treated for "Malaria" or "Typhoid" on several 
occasions with a poor response, often complicat-
ed by the development of oral candidiasis while 
taking antibiotics. 
In view of the major breach of immune 
defences AIDS patients are susceptable to a wide 
range of infections and therefore very variable 
clinical presentation. The initial signs and 
symptoms can be found in virtually any system 
and as such are usually not very specspecific. 
The only syndrome seen in Malawi which is 
almost exclusively associated with AIDS is 
atypical Kaposi's Sarcoma (A.K.S.). This has 
been found in almost 50% of the cases so far seen 
in Malawi. 
Comparison of atypical and typical Kaposi's scarcoma. (K.S.) 
Age of onset 
Progress 
Visceral disemination 
Response to treatment 









Distribution of skin leisions and lymphadenopathy 
20 
Atypical K.S. Typical K.S. 
Palate 
lesions 
Lymphnode form with no skin Lymphnode form with no skin 
leisons common. Generalised ieisons only seen in children. 
symetrical rubbery glands 
characteristic. 
In the absence of obvious AKS the following 
require close inspection when AIDS is suspected: 
(likely opportunistic infection or malignancy) 
General - Evidence ~f recent weight loss. Fever 
often present. 
Skin - Non specific often itchy maculo-papular 
rashes. 
- Herpe Zoster rash. 
- Perianal and periontl ulceration. 
(Candida, herpes simplex.) 
Mouth - Candidasis often very severe and resistant 
to treatment. 
- Patchy erythema of the soft palate and 
fauces 
- Tonsils enlarged. 
Fundi - Exudates often extending into vitreous 
with heamorrhages. (Cytomegalovirus re-
tinitis.) 
Lymph nodes - Some lymphadenopathy common, often 
svmetrical. non tender and most fre-
q'uently present in the neck and axillae. 









































Chest - Oilateral crackles 
(T.O., Pneumoc:ystic carinii) 
Abdomen· - Hepato-spleen~megaly 
(T.O .• lymphoma) 
Neurological - Occasioplly mood-disturbance, dementia 
or focal neurological signs. 
(T.O" Toxoplasma, cryptococcus, direct 
invasion by HTL V ·111) 
The diagnosis of AIDS (in the absence of AKS) 
as opposed to ARC depends on the positive 
diagnosis of an opportunistic infection. This 
presents difficulties in Malawi as the facilities to 
confirm the presence of some of these infections 
are not readily available; hence patients may be 
classified as ARC when they really already have 
full blown AIDS. This will become apparent as 
the patient's progress is followed. Alternatively a 
patient with symptoms suggestive of ARC may 
be found to have Tuberculosis and this is then 
assumed to be the sole underlying cause of the 
patient's condition; evidence of. ARC . only 
becoming apparent when the patient fads to 
respond well to antituberculous treatment or 
they develop persistant oral candidiasis. 
Epidemiology 
Characteristics of group at greatest risk in 
Malawi. 
Sex ratio: approximately equal 
Age: 20·40 
Edllcation level: above average, most patients 
speak good English. 
Foreign tral'el: greater than average 
Income: greater than average 
Mode of Transmission 
Definite. 
Sexual intercourse - this is the major route 
of transmission. Multiple partners. 
Blood Transfusion 
Contaminated needles and syringes 
Vertical transmission from mother to child 
Possible but unproven. 
Scarification (likely) 
Insect bites (unlikely) 
Investigations 
Laboratory investigations helpful in establish-
ing AIDS/ARC in patients with. s~ggestive 
clinical picture (finding suggestive of 
AIDS/ARC). 













Other investigations such as T -lymphocyte 
subset ratios and lymphocyte culture for 
HTLV-III are helpful but are not available. 
Other investigations may be required depending 
on clinical findings to exclude other diseases and 
confirm opportunistic infection. • 
Treatment 
There is no specific treatment for AIDS at 
present. Infections detected in such patie~ts, eg 
oral candidiasis or T.B., should be treated m the 
usual way. In severe pneumonia with cyanosis 
. and bilateral infiltrates a trial of high dose 
Cotrimoxazole (one tablet per 4 Kg body 
weight/day in four divided doses) is i~dicate~ ~s 
this may be due to pneumocys\ls cannn. 
Facilities to confirm this are not available at 
present. 
Infection control measures 
HTLV-III is not communicated easily. It 
appears to be less easily transmitted than 
Hepatitis B, a disease which can be sprea~ by 
similar routes and also carries an appreciable 
long term risk of a fatal outcome. It is therefore 
reasonable to adopt similar precautions for both 
diseases. The following measures are recom-
mended when dealing with any patient who is 
known or suspected to be HTLV -III positive. 
The measures recommended are little more than 
should be adopted when dealing with any 
potentially infectious body fluid. It must be 
remembered however that most individuals who 
are HTLV -III positive will be unrecognised 
carriers. 
Measures to reduce risk to medical staff 
- Contact with blo<Xl and secretions should be 
avoided. 
- Wear gloves and gown when mopping up 
any spilt blood, haematemesis or melaena, 
or when dressing any cutaneous ulcers. 
Floors or mattresses which have been 
contaminated by blo<Xl should be washed 
with household bleach diluted I: I 0 with 
water. 
- Dispose of contaminated dressings in plastic 
bags which should then be tied to prevent . 
spillage. . . 
- Always take blo<Xl with care. Wear cheap 
disposable gloves when venesecting a known 
case. 
- Dispose of any needles carefully so that 
cleaning staff will not prick themselves. Ifto 










































first in a separate kidney dish. 
- Do not attempt mouth to mouth resucita-
tion. 
- Ensure that colleagues eg theatre statT or 
laboratory statT are aware of the potential 
risk. Label all blood samples clearly as high 
risk specimens thus: HTLV-III risk. 
- Ensure that any minor injuries on your 
hands are dressed so that contact is avoided 
with potentially infected body fluid. 
- Ifblood is spilt on skin wash throughly with 
soap and water. If a needle stick injury is 
sustained encourage it to bleed then wash. 
Measures to reduce risk to other patients 
- A single room is only required if patients 
excreting infectious material, ego has exten-
sive open wounds, haemetemesis etc. 
Patients may be placed in a single room as a 
reminder to statTbut this should not displace 
patients with much more contagious 
diseases such cholera. 
- Ensure that any needles or syringes used 
with HTLV-III positive patients are ade-
quately sterilised preferably by autoclave. 
. Advice to be given to outpatients so that they may 
minimise the risk they pose to others 
It is a difficult task to phrase such advice both 
tactfully and clearly. More educated patients will 
often already have learnt something about AIDS, 
often grossly inaccurate and alarmist, from the 
popular press. It is often sensible to begin by 
discovering how much the patient knows so that 
any misconceptions can be rectified. It may be 
best to avoid the word AIDS and explain that 
their blood contains a virus which suppresses 
their ability to combat infection. 
Patients should know that their blood is 
infectious and that intimate contact such as 
sexual intercourse is a major route of infection. It 
is almost inevitable that the patients spouse has 
already been exposed to the infection for several 
months if not years prior to the patient 
presenting and little will be gained and 
potentially a great deal of unnecessary misery 
caused by any recommendation to alter a 
couples sexual practises at this stage. 
Recommendations that may be made: 
(Be selective, many of these will be inappro-
priate for sick patients) 
- No new sexual partners 
- If the patient cannot tolerate thi;, restriction 
the use of a condom should be encouraged, 
as it probably reduces but does not exclude, 
the risk of transmission. 
- The patient must never give blood. 
- The patient should make sure they tell 
unfamiliar medical statTtheir diagnosis. 
- Care should be taken with razors and 
toothbrushes which might become conta-
minated with blood to ensure that they are 
not shared by other members of the house-
hold. 
- If the patient insists on having traditional 
scarification treatment he should supply a 
razor blade for the therapist to use and then 
make sure it is returned. 
Medical statT found to be carriers should 
continue working. In order for them to transmit 
the infection whilst performing clinical duties, 
they would need to bleed, and for some of their 
blood to enter the patient's body. e.g. through a 
surgical incision, or via a mucous membrane. 
This unlikely route of transmission has never 
been recorded. Nevertheless they should 
probably avoid regularly conducting surgical or 
dental procedures, although they can quite safely 
take blood, dress wounds etc. There is no 
indication for the patient who is an asympto-
matic HTLV -III carrier to be moved to a 
non-clinical post. 
Confidentiality is all important if the patient's 
trust is to be gained. An employer should not be 
informed of the diagnosis without the patients 
consent. Discharge slips which an employer may 
ask to see should not carry the word AIDS; 
HTL V -III related disease should be written 
instead. Carriers whose job does not entail any 
unusual degree of physical intimacy should 
continue in such work. All health workers have 
an obligation to combat inappropriate stigmati-
sation of HTLV -Ill carriers. 
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